Corporate Magazine 2012 - Boehringer Ingelheim

Core business secures new growth initiativesWe plan long-term, over generations. A stable core business with safe and effectivemedicines creates the freedom and security to also think about completelynew types of growth initiatives, free from economic cycles, especially in currenttimes when the pharmaceutical environment is undergoing dynamic change. In avolatile environment we have, due to our solid development, the strength to reactwith agility and flexibility.Employees the strongest innovative forceWith our stability as an independent, family-owned company and our long-termplanning horizon, we give our employees the space and the freedom to develop aportfolio of innovative ideas. This has created a trusting and responsible environmentand thereby the unmistakeable corporate culture at Boehringer Ingelheim.A set of values, which we live out with our employees, places our employees in theforeground as the decisive success factor and its most important innovative force.Research and development partnershipsWe have established research and development partnerships with biotechnologycompanies, universities and basic research institutions. With the Research Instituteof Molecular Pathology (IMP) in Vienna, Austria, Boehringer Ingelheim supportsan institution that works exclusively with basic research. This enables thecompany, in cooperation with the scientific community, to integrate external innovationsinto the company in dependable and trustful partnership.Furthermore, we have set up a partnership with the non-governmental organisationAshoka within the framework of our “Making More Health“ initiative. Wecooperate with social entrepreneurs in the field of health projects and therebywant to learn how our partners design and further develop innovative solutionsin the area of healthcare provision using novel and sustainable approaches.8Boehringer Ingelheim annual report 2012